Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Genet., 07 October 2025

Sec. Cancer Genetics and Oncogenomics

Volume 16 - 2025 | https://doi.org/10.3389/fgene.2025.1684479

Correction: FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway

This article is a correction to:

  1. FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway

    1. Read original article
Xiaoping Yang,Xiaoping Yang1,2Zuohui YuanZuohui Yuan2Lingzhu GouLingzhu Gou1Long ChengLong Cheng1Zirui WangZirui Wang3Pingfan WuPingfan Wu4Xiaochun WangXiaochun Wang2Xueni MaXueni Ma1Tiantian MaTiantian Ma5Yi YuYi Yu6Zhiping WuZhiping Wu6Dekui Zhang, Dekui Zhang1,6*
  • 1Key Laboratory of Digestive Diseases of Gansu Province, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China
  • 2Department of Gastroenterology, Gansu Provincial Hospital, Lanzhou, China
  • 3Department of Urology, The Second People’s Hospital of Lanzhou, Lanzhou, China
  • 4Department of Pathology, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, China
  • 5Department of Pneumology, Xi An Chest Hospital, Xian, China
  • 6Department of Gastroenterology, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China

A Correction on
FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway

by Yang X, Yuan Z, Gou L, Cheng L, Wang Z, Wu P, Wang X, Ma X, Ma T, Yu Y, Wu Z and Zhang D (2025). Front. Genet. 16:1514205. doi: 10.3389/fgene.2025.1514205

Affiliations 1 and 2 were numbered in the wrong order.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: FEZF1-AS1, colon cancer, autophagy, PI3K/AKT/mTOR, chemosensitivity

Citation: Yang X, Yuan Z, Gou L, Cheng L, Wang Z, Wu P, Wang X, Ma X, Ma T, Yu Y, Wu Z and Zhang D (2025) Correction: FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway. Front. Genet. 16:1684479. doi: 10.3389/fgene.2025.1684479

Received: 12 August 2025; Accepted: 05 September 2025;
Published: 07 October 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Yang, Yuan, Gou, Cheng, Wang, Wu, Wang, Ma, Ma, Yu, Wu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Dekui Zhang, emhhbmdkazg2MTZAMTI2LmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.